Opioid Use Disorder (OUD) Market Outlook, Insights, Size 2024-2033

"The Business Research Company recently released a comprehensive report on the Global Opioid Use Disorder (OUD) Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=12586&type=smp

According to The Business Research Company's, The opioid use disorder (oud) market size has grown rapidly in recent years. It will grow from $3.53 billion in 2023 to $3.93 billion in 2024 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to increased prescription rates, pain management practices, drug marketing, stigmatization of addiction.

The opioid use disorder (oud) market size is expected to see rapid growth in the next few years. It will grow to $6.04 billion in 2028 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to regulatory interventions, focus on alternative pain management, expansion of treatment access, public health initiatives, . Major trends in the forecast period include technological innovations in treatment, individualized treatment approaches, integrated care models, community-based support programs, early intervention and prevention.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

Market Drivers and Trends:

The growing number of opioid addiction cases is expected to propel the growth of the opioid use disorder (OUD) market going forward. Opioid addiction refers to a medical condition characterized by compulsive and chronic opioid use that has harmful effects on the body. Opioids can produce a sense of euphoria and pain relief, whose continued usage can lead to the development of tolerance, where higher doses are needed to achieve the same effect, which may lead to opioid use disorder. For instance, in May 2022, according to the Centers for Disease Control and Prevention, a US-based government agency, opioid overdose deaths in the USA increased by 15% from 70,029 in 2020 to 80,816 in 2021. Therefore, the growing number of opioid addiction cases drives the growth of the opioid use disorder (OUD) market.

Product innovation is a key trend gaining popularity in the opioid use disorder (OUD) market. Major companies operating in the opioid use disorder (OUD) market are developing innovative products to sustain their position in the market. For instance, in May 2023, the U.S. Food and Drug Administration, a US-based federal agency, approved Brixadi (buprenorphine) extended-release injection to treat moderate to severe opioid use disorder (OUD). Brixadi is available in two dosage forms a weekly injection for patients who began treatment with a single dose of a transmucosal buprenorphine product or who are currently taking the medication and a monthly version for those who are already receiving the medication.

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Major Key Players of the Market:

Pfizer Inc., Novartis AG, AstraZeneca plc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Chiesi Pharmaceuticals S.p.A., Hikma Pharmaceuticals Plc., Mallinckrodt Pharmaceuticals, Indivior Plc., Knight Therapeutics Inc., Purdue Pharma L.P, Alkermes Inc., Collegium Pharmaceutical Inc., Vanda Pharmaceuticals Inc., Camurus AB, Tris Pharma Inc., Mylan NV., Orexo US Inc., Zogenix Inc., Rhodes Pharmaceuticals L.P., Omeros Corporation, Braeburn Pharmaceuticals Inc., Adapt Pharma Inc., Titan Pharmaceuticals Inc., BioDelivery Sciences International Inc., Insys Therapeutics Inc., MediciNova Inc., Cara Therapeutics Inc., AcelRx Pharmaceuticals Inc., KemPharm Inc.,

Opioid Use Disorder (OUD) Market 2024 Key Insights:

• The opioid use disorder (oud) market size is expected to see rapid growth in the next few years. It will grow to $6.04 billion in 2028 at a compound annual growth rate (CAGR) of 11.3%.
• The Growing Number Of Opioid Addiction Cases
• FDA Approval Of Brixadi Marks A Milestone In Opioid Use Disorder (OUD) Market Through Innovative Treatment Options
• North America was the largest region in the opioid use disorder (OUD) market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=12586&type=smp

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

"""Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide."

This release was published on openPR.